Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

Agenus Inc. CEO Garo Armen received 5,931 shares of common stock as compensation in lieu of cash salary for the pay period ending December 27, 2024.

Summary

• Garo H. Armen, CEO of Agenus Inc., received 5,931 shares of Agenus common stock on December 27, 2024, as part of his compensation.
• This stock payment was made in lieu of cash salary, with the approval of the Agenus Inc. Compensation Committee.
• The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested upon issuance.
• The price of the stock was $2.75 per share, which was the closing price of Agenus common stock on December 27, 2024.
• Following the transaction, Armen directly owns 124,371 shares.
• Armen also indirectly owns 31,298 shares through his IRA accounts and 28,950 shares as trustee and investment authority for the Garo Armen 2020 2 Year AG GRAT and as a general partner in Pixie Partners.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a routine transaction of stock compensation. The fact that the CEO is taking stock instead of cash could be seen as a positive sign, but it's not a major event.

Positives

• The CEO's acceptance of stock in lieu of cash salary may be viewed positively by investors as it aligns his interests with those of the shareholders.
• The shares are fully vested on the date of issuance, providing immediate ownership and potential benefit from future stock appreciation.

Industry Context

In the biotechnology industry, it is not uncommon for executives to receive stock-based compensation as part of their overall remuneration packages. This practice is intended to align the interests of management with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded biotechnology companies.
• Companies like Amgen, Gilead Sciences, and Biogen often use stock options, restricted stock units (RSUs), and performance-based equity awards to compensate their executives.
• The specific amount and structure of stock-based compensation vary depending on the company's size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the CEO's acceptance of stock in lieu of cash salary as a positive sign, aligning his interests with theirs.
• Employees may see this as a sign of confidence in the company's future prospects.

Key Dates